title: The global alliance for tuberculosis drug development--accomplishments and future directions.
abstract: The Global Alliance for Tuberculosis Drug Development (TB Alliance) aims to stop the spread of tuberculosis by developing new, faster-acting, and affordable tuberculosis drugs. The TB Alliance is a public-private partnership, a not-for-profit enterprise, that draws upon the resources of both private and public institutions to help address this urgent health need. This article summarizes some of the achievements of the TB Alliance to date and outlines potential future directions.
authors.affiliation: The Rockefeller Foundation, 420 Fifth Avenue, New York, NY 10018, USA. cgardner@rockfound.org
authors.forename: Charles A
authors.initials: CA
authors.lastname: Gardner
authors.forename: Tara
authors.initials: T
authors.lastname: Acharya
authors.forename: Ariel
authors.initials: A
authors.lastname: Pablos-Méndez
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D015195:Drug Design; D014943:Global Health; D006801:Humans; D014376:Tuberculosis / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents